Home › Free Stock Grades › ORIC
ORIC Pharmaceuticals, Inc. (ORIC) Stock Grade
ORIC · Healthcare
C
Market Cap
$1.4B
P/E Ratio
—
Revenue Growth (YoY)
0.0%
Net Margin
0.0%
Return on Equity
—
Dividend Yield
None
About ORIC Pharmaceuticals, Inc.'s fundamentals
ORIC Pharmaceuticals is a biotechnology company with a market capitalization of $1.4 billion that reported flat revenue growth year-over-year at 0.0%. The company posted a net loss in its latest annual statement, resulting in a net margin of 0.0%, and does not pay a dividend. As a pre-profitability biotech firm, traditional valuation metrics like P/E ratio and return on equity are not applicable, which is typical for early-stage pharmaceutical companies focused on drug development and regulatory approval.